Corrigendum to 'A phase II evaluation of mifepristone in the treatment of recurrent or persistent epithelial ovarian, fallopian or primary peritoneal cancer: A gynecologic oncology group study' [Gynecol. Oncol. 116 (2010)]

Autor:	Mark S. Shahin, William E. Brady, Thomas F. Rocereto, Laurie Small, Robert S. Mannel, Jacob Rotmensch, James S. Hoffman
Rok vydání:	2010
Předmět:	Gynecology medicine.medical_specialty Oncology Peritoneal cancer Group study Roswell Park Cancer Institute business.industry medicine Obstetrics and Gynecology Gynecologic oncology University hospital business
Zdroj:	Gynecologic Oncology. 118:208
ISSN:	0090-8258
DOI:	10.1016/j.ygyno.2010.04.019
Popis:	a Cooper University Hospital, Camden, NJ 08103, USA b Gynecologic Oncology Group Statistical and Data Center, Roswell Park Cancer Institute, Buffalo, NY 14263, USA c Abington Memorial Hospital, Abington, PA 19001, USA d The Hospital of Central Connecticut, New Britain, CT 06050, USA e Maine Medical Center, Portland, ME 04102, USA f Rush-Presbyterian St. Lukes Medical Center, Chicago, IL 60612, USA g University of Oklahoma, Oklahoma City, OK 73190, USA
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::b9f90aadd471fedd5dfd61af45aac6ec https://doi.org/10.1016/j.ygyno.2010.04.019 Zobrazit plný text záznamu Full Text from ScienceDirect